New combo aims to stop postpartum bleeding in bleeding disorder patients

This study tested whether adding tranexamic acid to a standard clotting factor drug (recombinant von Willebrand factor) can better prevent heavy bleeding after childbirth in women with von Willebrand disease. Twenty pregnant women with the condition were randomly assigned to receive either the combination or the clotting factor alone during delivery. The main goal was to measure blood loss at birth, with follow-up for three weeks to check safety and bleeding control.